BRIDGEBIO PHARMA INC.
25.88
07-11月-24 15:59:59
15 分の遅延
株式
+0.27
+1.05%
本日の幅
25.34 - 26.15
ISIN
N/A
ソース
NASDAQ
-
05 11 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
24 10 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
30 9 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
17 9 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
10 9 2024 16:45:00 提供 Nasdaq GlobeNewswire
-
10 9 2024 16:45:00 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
06 9 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
30 8 2024 10:50:00 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma to Participate in September Investor Events
28 8 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
BridgeBio Launches MyAchonJourney, a New Resource for Families Navigating Achondroplasia
19 8 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
08 8 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Second Quarter 2024 Financial Results and Business Update
01 8 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
BridgeBio Announces Appointment of Thomas Trimarchi, Ph.D., as President and Chief Operating Officer
23 7 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
05 7 2024 16:31:00 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
10 6 2024 07:30:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >